Structure-Guided Identification of JAK2 Inhibitors: From Similarity to Stability and Specificity
Future Pharmacology · 05.11.2025 · 5 (4) · 66
DOI: 10.3390/futurepharmacol5040066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 05.11.2025. Verfasst von Muhammad Yasir und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Regional Innovation System & Education (RISE) program, Korea Basic Science Institute.
Abstract (Originalsprache)
Background/Objectives: Janus kinase 2 (JAK2) is a pivotal signaling protein implicated in various hematological malignancies and inflammatory disorders, making it a compelling target for therapeutic intervention.
Methods
In this study, we employed an integrative computational approach combining ligand-based screening, pharmacophore modeling, molecular docking, molecular dynamics (MD) simulations, and MM/PBSA free energy calculations to identify JAK2 inhibitors from the ChEMBL database. A comprehensive virtual screening of over 1,900,000 compounds was conducted using Tanimoto similarity and a validated pharmacophore model, resulting in the identification of 39 structurally promising candidates. Docking analyses prioritized compounds with favorable interaction energies, while MD simulations over 100 ns assessed the dynamic behavior and binding stability of top hits.
Results
Four compounds, CHEMBL4169802, CHEMBL4162254, CHEMBL4286867, and CHEMBL2208033, exhibited consistently superior performance, forming stable hydrogen bonds, favorable RMSD profiles (≤0.5 nm), and strong binding interactions, including salt bridges. Notably, the binding free energies revealed ΔG values as low as −29.91 kcal/mol, surpassing that of the reference inhibitor, momelotinib (−24.17 kcal/mol).
Conclusions
Among these, CHEMBL4169802 emerged as the most promising candidate due to its synergistic electrostatic and hydrophobic interactions. Collectively, our results highlight these compounds as probable, JAK2-selective inhibitors with strong potential for further biological validation and optimization.
Förderung
- National Research Foundation of Korea
- Regional Innovation System & Education (RISE) program
- Korea Basic Science Institute
Zitieren
APA
Yasir, M., Park, J., Choe, J., Han, J., Han, E., Park, W. S., & Chun, W. (2025). Structure-Guided Identification of JAK2 Inhibitors: From Similarity to Stability and Specificity. Future Pharmacology, 5(4), 66. https://doi.org/10.3390/futurepharmacol5040066
Vancouver
Yasir M, Park J, Choe J, Han J, Han E, Park WS, et al. Structure-Guided Identification of JAK2 Inhibitors: From Similarity to Stability and Specificity. Future Pharmacology. 2025;5(4):66. doi:10.3390/futurepharmacol5040066
BibTeX
@article{Yasir2025,
author = {Yasir, Muhammad and Park, Jinyoung and Choe, Jongseon and Han, Jin-Hee and Han, Eun-Taek and Park, Won Sun and Chun, Wanjoo},
title = {Structure-Guided Identification of JAK2 Inhibitors: From Similarity to Stability and Specificity},
journal = {Future Pharmacology},
year = {2025},
volume = {5},
number = {4},
pages = {66},
doi = {10.3390/futurepharmacol5040066}
}
EUVIMED